Synovus Financial’s Pediatrix Medical MD Stock Holding History

Synovus Financial’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-47	Closed	-$1K	–	1898
2020 Q1	$1K	Buy	+47	New	+$969	﹤0.01%	2041

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Synovus Financial's MD Position: Q2 2020 in Review

Synovus Financial sold out of Pediatrix Medical (MD) in Q2 2020, closing a stake of 47 shares — an estimated $1K sold.

Synovus Financial first reported a position in MD in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 215 funds tracked by Wall St. Rank hold MD as of Q2 2020.

Synovus Financial reported no remaining Pediatrix Medical position as of Q2 2020 after selling out during the quarter.
Synovus Financial sold 47 Pediatrix Medical shares in Q2 2020, an estimated $1K.
Synovus Financial first reported a position in Pediatrix Medical in Q1 2020 and held it in 1 quarter.
Synovus Financial's Pediatrix Medical position peaked at $1K in Q1 2020.
215 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.